Implicit Bioscience
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
L 1 32 Logan Rd, Woolloongabba, Queensla...Phone Number
+61 737211210Website
www.implicitbioscience.comRevenue
<$5 MillionIndustry
About Implicit Bioscience
Implicit Bioscience is focused on transforming immunotherapy through its lead therapeutic candidate, IC14, an investigational anti-CD14 monoclonal antibody. This innovative treatment aims to regulate inflammatory responses related to various diseases, including motor neurone disease, cardioimmunology, and acute respiratory distress syndrome. The company collaborates with leading experts in medical research and welcomes investment from philanthropists and private investors. With a commitment to addressing chronic diseases linked to inappropriate inflammation, Implicit Bioscience is poised to make significant advancements in the field of immunotherapy.Explore more
SIC Code 28,283NAICS Code 32,325Show moreImplicit Bioscience Org Chart
Compare Similar Companies to Implicit Bioscience
Compare insights from companies similar to Implicit Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Implicit Bioscience Tech Stack
A closer look at the technologies used by Implicit Bioscience
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Implicit Bioscience
Sign Up For FreeTo access detailed company insights
Implicit Bioscience is focused on transforming immunotherapy through its lead therapeutic candidate, IC14, an investigational anti-CD14 monoclonal antibody. This innovative treatment aims to regulate inflammatory responses related to various diseases, including motor neurone disease, cardioimmunology, and acute respiratory distress syndrome. The co... Read More